Literature DB >> 9068295

Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres.

A Vellodi1, E P Young, A Cooper, J E Wraith, B Winchester, C Meaney, U Ramaswami, A Will.   

Abstract

Bone marrow transplantation was carried out on 38 patients with mucopolysaccharidosis type I over a period of 15 years. The donor was an HLA identical relative in 10 cases, an HLA non-identical relative in 16 cases, and an HLA identical unrelated volunteer donor in 12 cases. Ten patients received a second transplant. One patient received three transplants. Thirteen engrafted patients have survived five years or more. Most patients have shown an arrest or slowing down of psychomotor regression. However, dysostosis multiplex has progressed. Careful selection of patients may be necessary to ensure optimum results.

Entities:  

Mesh:

Year:  1997        PMID: 9068295      PMCID: PMC1717089          DOI: 10.1136/adc.76.2.92

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  21 in total

1.  Amplification of a variable number of tandem repeats (VNTR) locus (pMCT118) by the polymerase chain reaction (PCR) and its application to forensic science.

Authors:  K Kasai; Y Nakamura; R White
Journal:  J Forensic Sci       Date:  1990-09       Impact factor: 1.832

2.  Amplification of the COL2A1 3' variable region used for segregation analysis in a family with the Stickler syndrome.

Authors:  L Priestley; D Kumar; B Sykes
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region.

Authors:  E Boerwinkle; W J Xiong; E Fourest; L Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

5.  Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation.

Authors:  P M Hoogerbrugge; K Suzuki; K Suzuki; B J Poorthuis; T Kobayashi; G Wagemaker; D W van Bekkum
Journal:  Science       Date:  1988-02-26       Impact factor: 47.728

Review 6.  The systemic mucopolysaccharidoses.

Authors:  J Spranger
Journal:  Ergeb Inn Med Kinderheilkd       Date:  1972

7.  Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation.

Authors:  J R Hobbs; K Hugh-Jones; A J Barrett; N Byrom; D Chambers; K Henry; D C James; C F Lucas; T R Rogers; P F Benson; L R Tansley; A D Patrick; J Mossman; E P Young
Journal:  Lancet       Date:  1981-10-03       Impact factor: 79.321

Review 8.  Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.

Authors:  H S Scott; S Bunge; A Gal; L A Clarke; C P Morris; J J Hopwood
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

9.  Long-term neurological effects of bone marrow transplantation in a canine lysosomal storage disease.

Authors:  R M Shull; M A Breider; G C Constantopoulos
Journal:  Pediatr Res       Date:  1988-09       Impact factor: 3.756

10.  Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I.

Authors:  M A Breider; R M Shull; G Constantopoulos
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

View more
  49 in total

Review 1.  Changes in clinical practice with the unravelling of diseases: connective-tissue disorders.

Authors:  J Spranger
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

Review 2.  New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010 Mar-Apr

3.  Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Drug Deliv Transl Res       Date:  2012-06-01       Impact factor: 4.617

4.  Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development.

Authors:  M A Baxter; R F Wynn; L Schyma; D K Holmes; J E Wraith; L J Fairbairn; I Bellantuono
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 5.  Treatment of lysosomal storage disorders : progress with enzyme replacement therapy.

Authors:  Marianne Rohrbach; Joe T R Clarke
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Prevalence and development of orthopaedic symptoms in the dutch hurler patient population after haematopoietic stem cell transplantation.

Authors:  F J Stoop; M C Kruyt; M H van der Linden; R J B Sakkers; P M van Hasselt; R M C Castelein
Journal:  JIMD Rep       Date:  2012-09-19

Review 7.  Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future.

Authors:  Madeleine Taylor; Shaukat Khan; Molly Stapleton; Jianmin Wang; Jing Chen; Robert Wynn; Hiromasa Yabe; Yasutsugu Chinen; Jaap Jan Boelens; Robert W Mason; Francyne Kubaski; Dafne D G Horovitz; Anneliese L Barth; Marta Serafini; Maria Ester Bernardo; Hironori Kobayashi; Kenji E Orii; Yasuyuki Suzuki; Tadao Orii; Shunji Tomatsu
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-14       Impact factor: 5.742

8.  Unrelated donor marrow transplantation for congenital immunodeficiency and metabolic disease: an update of the experience of the Japan Marrow Donor Program.

Authors:  Naoki Sakata; Keisei Kawa; Koji Kato; Hiromasa Yabe; Miharu Yabe; Masayuki Nagasawa; Hideo Mugishima; Hisato Kigasawa; Masahiro Tsuchida; Yuichi Akiyama; Yasuo Morisima; Yoshihisa Kodera; Shunichi Kato
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

9.  Effect of elongation factor 1alpha promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase.

Authors:  Carlos J Alméciga-Díaz; Maria A Rueda-Paramo; Angela J Espejo; Olga Y Echeverri; Adriana Montaño; Shunji Tomatsu; Luis A Barrera
Journal:  Mol Biol Rep       Date:  2008-11-07       Impact factor: 2.316

10.  alpha-L-iduronidase therapy for mucopolysaccharidosis type I.

Authors:  Jakub Tolar; Paul J Orchard
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.